Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.31 USD | -1.47% | +2.76% | +33.58% |
05-08 | Revolution Medicines Q1 Net Loss Narrows | MT |
04-12 | Oppenheimer Adjusts Revolution Medicines Price Target to $45 From $43, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- RVMD Stock
- News Revolution Medicines, Inc.
- MarketScreener Strategies